Diagnosis and Management of Myelodysplastic Syndromes
A Clinical Guide
Seiten
2021
|
1st ed. 2020
Springer International Publishing (Verlag)
978-3-030-51880-6 (ISBN)
Springer International Publishing (Verlag)
978-3-030-51880-6 (ISBN)
Myelodysplastic syndromes (MDS) are a group of clonal disorders characterized by pancytopenias and the risk of progression to acute myeloid leukemia. The diagnosis of MDS can be challenging, while the outcomes of MDS patients vary widely. This book provides a concise yet comprehensive overview of MDS.
The book begins by reviewing the diagnostic workup of MDS, with a specific focus on the 2016 WHO criteria for MDS diagnosis, and the biology and pathophysiology of the disease. The text then presents the molecular landscape of MDS and its impact on disease diagnosis, prognosis, and treatment decisions. The book continues by profiling different prognostic models of MDS and concludes with a thorough review of treatment algorithms for lower and higher-risk MDS, as well as the use of hematopoietic stem cell transplant to combat the disease.
Written by experts in the field, Diagnosis and Management of Myelodysplastic Syndromes: A Clinical Guide is a valuable resource for clinicians, practitioners, and researchers who are interested in MDS. The text also features over 100 illustrations, photographs, and tables.
The book begins by reviewing the diagnostic workup of MDS, with a specific focus on the 2016 WHO criteria for MDS diagnosis, and the biology and pathophysiology of the disease. The text then presents the molecular landscape of MDS and its impact on disease diagnosis, prognosis, and treatment decisions. The book continues by profiling different prognostic models of MDS and concludes with a thorough review of treatment algorithms for lower and higher-risk MDS, as well as the use of hematopoietic stem cell transplant to combat the disease.
Written by experts in the field, Diagnosis and Management of Myelodysplastic Syndromes: A Clinical Guide is a valuable resource for clinicians, practitioners, and researchers who are interested in MDS. The text also features over 100 illustrations, photographs, and tables.
Aziz Nazha, MDCleveland ClinicDepartment of Hematology and Medical OncologyTaussig Cancer InstituteCleveland, OH USA
Epidemiology, Etiology, and Clinical Presentation of Myelodyplastic Syndromes.- Morphological, Flow Cytometry, and Cytogenetic Diagnosis of MDS.- Biology and Pathophysiology of MDS with del5q.- MDS Stem Cell Biology.- Molecular Landscape of MDS.- MDS Mimics (CHIP, ICUS, CCUS).- Prognostic Models in Myelodyplastic Syndromes.- Treatment Algorithms for Lower-risk Disease.- Treatment Algorithms for Higher-risk Disease.- Hematopoietic Cell Transplantation for MDS Patients.
| Erscheinungsdatum | 18.08.2021 |
|---|---|
| Zusatzinfo | XII, 179 p. 29 illus., 28 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 155 x 235 mm |
| Gewicht | 369 g |
| Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Hämatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Schlagworte | azacitidine • CCUS • Chip • decitabine • HSCT • ICUS • Lenalidomide |
| ISBN-10 | 3-030-51880-9 / 3030518809 |
| ISBN-13 | 978-3-030-51880-6 / 9783030518806 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Hämatologie und Internistische Onkologie
Buch | Softcover (2023)
ecomed-Storck GmbH (Verlag)
CHF 179,95
Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 73,00
